Mitapivat for Beta Thalassemia Transfusion Dependent
Phase-Based Progress Estimates
2
Effectiveness
3
Safety
Beta Thalassemia Transfusion Dependent+1 MoreMitapivat - Drug
You have a chance of qualifying for this trial. We made sure your application will take less than 5 minutes.
Eligibility
18+
All Sexes
What conditions do you have?
Select
Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
This trial will compare the effect of the drug mitapivat versus a placebo on transfusion burden in people with transfusion-dependent alpha- or beta-thalassemia.